<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immune evasion strategies &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/immune-evasion-strategies/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 08 Oct 2025 09:20:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Immune evasion strategies &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Harnessing Engineered “Natural Killer” Cells to Combat Cancer</title>
		<link>https://bioengineer.org/harnessing-engineered-natural-killer-cells-to-combat-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 08 Oct 2025 09:19:50 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[CAR-NK cells]]></category>
		<category><![CDATA[genetic engineering in oncology]]></category>
		<category><![CDATA[Immune evasion strategies]]></category>
		<category><![CDATA[MIT-Harvard medical research]]></category>
		<guid isPermaLink="false">https://bioengineer.org/harnessing-engineered-natural-killer-cells-to-combat-cancer/</guid>

					<description><![CDATA[In a significant leap forward for cancer immunotherapy, researchers at MIT and Harvard Medical School have unveiled an innovative method to genetically engineer chimeric antigen receptor natural killer (CAR-NK) cells that exhibit enhanced anti-tumor efficacy while evading immune rejection. This breakthrough addresses a persistent challenge in cellular immunotherapy: the host immune system’s propensity to recognize [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">277446</post-id>	</item>
		<item>
		<title>RNA Modifications May Play a Role in the Onset of Autoimmune Disorders</title>
		<link>https://bioengineer.org/rna-modifications-may-play-a-role-in-the-onset-of-autoimmune-disorders/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 07 Aug 2025 10:21:02 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Autoimmune disease mechanisms]]></category>
		<category><![CDATA[Glycobiology in immunity]]></category>
		<category><![CDATA[Immune evasion strategies]]></category>
		<category><![CDATA[Innate immune response]]></category>
		<category><![CDATA[RNA N-glycosylation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/rna-modifications-may-play-a-role-in-the-onset-of-autoimmune-disorders/</guid>

					<description><![CDATA[A groundbreaking study recently published in Nature unveils a novel and transformative mechanism by which cells avoid self-inflicted immune responses through a sophisticated chemical modification of RNA. Spearheaded by Ryan Flynn, MD, PhD, in collaboration with Vijay Rathinam, DVM, PhD, and graduate student Vincent Graziano from UConn Health, alongside researchers at Boston Children’s Hospital, this [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">254337</post-id>	</item>
	</channel>
</rss>
